These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23052696)

  • 1. A nine-gene signature predicting clinical outcome in cutaneous melanoma.
    Brunner G; Reitz M; Heinecke A; Lippold A; Berking C; Suter L; Atzpodien J
    J Cancer Res Clin Oncol; 2013 Feb; 139(2):249-58. PubMed ID: 23052696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
    Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
    J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.
    Nsengimana J; Laye J; Filia A; Walker C; Jewell R; Van den Oord JJ; Wolter P; Patel P; Sucker A; Schadendorf D; Jönsson GB; Bishop DT; Newton-Bishop J
    Oncotarget; 2015 May; 6(13):11683-93. PubMed ID: 25871393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma.
    Amaral TMS; Hoffmann MC; Sinnberg T; Niessner H; Sülberg H; Eigentler TK; Garbe C
    Eur J Cancer; 2020 Jan; 125():38-45. PubMed ID: 31838403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
    Thakur R; Laye JP; Lauss M; Diaz JMS; O'Shea SJ; Poźniak J; Filia A; Harland M; Gascoyne J; Randerson-Moor JA; Chan M; Mell T; Jönsson G; Bishop DT; Newton-Bishop J; Barrett JH; Nsengimana J
    Clin Cancer Res; 2019 Dec; 25(24):7424-7435. PubMed ID: 31515461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging.
    Brunner G; Heinecke A; Falk TM; Ertas B; Blödorn-Schlicht N; Schulze HJ; Suter L; Atzpodien J; Berking C
    JNCI Cancer Spectr; 2018 Jul; 2(3):pky032. PubMed ID: 31360859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma.
    Keller J; Schwartz TL; Lizalek JM; Chang ES; Patel AD; Hurley MY; Hsueh EC
    Cancer Med; 2019 May; 8(5):2205-2212. PubMed ID: 30950242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
    Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
    J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma.
    Hsueh EC; DeBloom JR; Lee JH; Sussman JJ; Covington KR; Caruso HG; Quick AP; Cook RW; Slingluff CL; McMasters KM
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
    Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
    Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.
    Raskin L; Fullen DR; Giordano TJ; Thomas DG; Frohm ML; Cha KB; Ahn J; Mukherjee B; Johnson TM; Gruber SB
    J Invest Dermatol; 2013 Nov; 133(11):2585-2592. PubMed ID: 23633021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients. A prospective multicentre cohort study.
    Podlipnik S; Carrera C; Boada A; Richarz NA; López-Estebaranz JL; Pinedo-Moraleda F; Elosua-González M; Martín-González MM; Carrillo-Gijón R; Redondo P; Moreno E; Malvehy J; Puig S
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):857-862. PubMed ID: 30702163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
    Qu Y; Zhang S; Zhang Y; Feng X; Wang F
    Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
    Gerami P; Cook RW; Wilkinson J; Russell MC; Dhillon N; Amaria RN; Gonzalez R; Lyle S; Johnson CE; Oelschlager KM; Jackson GL; Greisinger AJ; Maetzold D; Delman KA; Lawson DH; Stone JF
    Clin Cancer Res; 2015 Jan; 21(1):175-83. PubMed ID: 25564571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
    Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
    Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.